G1 Therapeutics, Inc. (GTHX) - Wutah bathi EPS kuartalan

Simbol resmi perusahaan G1 Therapeutics Inc. (GTHX)

G1 Therapeutics, Inc. (GTHX) is optimizing hospital supply chains in preparation for a merger with a global pharma behemoth to scale its developments. The quarterly EPS dynamics captured on the GURU.Markets chart demonstrate a fundamental trend, where -172.80 represents the current level of the metric. Business revenues are based on the sale of the drug Cosela for the protection of bone marrow in lung cancer patients.

Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan G1 Therapeutics (GTHX): kanggo periode 04.07.2022 - 28.09.2024

Rincian analitis perusahaan G1 Therapeutics, Inc.

Analisis fundamental perusahaan:G1 Therapeutics Inc., GTHX
Produk asil prodhuksi G1 Therapeutics, Inc.

For G1 Therapeutics, Inc. (GTHX), the transition to licensing royalties and portfolio diversification makes net income dynamics a key indicator of the business model transformation's effectiveness. By analyzing the history of quarterly EPS growth, investors assess the rate of change in earnings per share, where the absence of a pronounced upward momentum in the calculations signals capital stagnation and high speculative risks.

Analisis perusahaan pesaing

Incyte Corporation (INCY) - Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan HUTCHMED Corp|NUVB (nuvationbio.com) - Wutah bathi EPS kuartalan|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan dayonebio.com (DAWN)|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan Monopar Corp (MNPR)|INBX - Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan I-Mab Inc. IMAB|Fennec - Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan|HRTX - Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan|Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan Nuvectis Pharma, Inc.|CHRS: Wutah bathi EPS kuartalan|Wutah bathi resik saben saham sajroning taun lumaku Corbus Pharma CRBP|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan CRDF|Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan BeyondSpring Inc. BYSI|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan BCAB (BioAtla Inc)|LIXT (Lixte Biotechnology Holdings, Inc.) - Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan|Citius Pharmaceuticals, Inc. - Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan|Kacepetan wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan CLRB (Cellectar Biosciences, Inc.)|BioLineRx Corp - Wutah bathi EPS kuartalan|Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan CANF (Can-Fite BioPharma, Ltd.)|APRE: Wutah bathi EPS kuartalan|Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan Kazia (KZIA)|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan silexion.com|NCNA: Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan|Wutah bathi EPS kuartalan CMRX|Wutah bathi EPS kuartalan Cyclacel, Inc. (CYCC)|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan Kronos Bio Corp KRON|KTRA (Kintara Therapeutics, Inc.) - Dinamika bathi resik saben saham taun-ka-taun sajrone rolas wulan pungkasan|ONCT: Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan|Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan Portage Biotech Inc